Related Experiment Video
Updated: Aug 28, 2025

Isolating Potentiated Hsp104 Variants Using Yeast Proteinopathy Models
Published on: November 11, 2014
J Proteins Counteract Amyloid Propagation and Toxicity in Yeast
Daniel C Masison1, Michael Reidy1, Jyotsna Kumar2
1Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
The accumulation of misfolded proteins as amyloids is associated with pathology in dozens of debilitating human disorders, including diabetes, Alzheimer's, Parkinson's, and Huntington's diseases. Expressing human amyloid-forming proteins in yeast is toxic, and yeast prions that propagate as infectious amyloid forms of cellular proteins are also harmful. The yeast system, which has been useful for studying amyloids and their toxic effects, has provided much insight into how amyloids affect cells and how cells respond to them. Given that an amyloid is a protein folding problem, it is unsurprising that the factors found to counteract the propagation or toxicity of amyloids in yeast involve protein quality control. Here, we discuss such factors with an emphasis on J-domain proteins (JDPs), which are the most highly abundant and diverse regulators of Hsp70 chaperones. The anti-amyloid effects of JDPs can be direct or require interaction with Hsp70.
Insights
Misfolded proteins forming amyloids cause diseases like Alzheimer's. J-domain proteins (JDPs) help counteract amyloid toxicity in yeast by regulating protein quality control, often with Hsp70 chaperones.
Area of Science:
- Biochemistry
- Cell Biology
- Neuroscience
Background:
- Amyloid protein accumulation is linked to neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's.
- Yeast models are valuable for studying amyloid toxicity and cellular responses to misfolded proteins.
Purpose of the Study:
- To explore protein quality control factors that counteract amyloid propagation and toxicity.
- To emphasize the role of J-domain proteins (JDPs) in managing amyloidogenic proteins.
Main Methods:
- Utilizing yeast as a model system to express human amyloid-forming proteins.
- Investigating the function of J-domain proteins (JDPs) and their interaction with Hsp70 chaperones.
Main Results:
- J-domain proteins (JDPs) are key regulators of Hsp70 chaperones and are abundant in yeast.
- JDPs demonstrate anti-amyloid effects, either directly or through Hsp70 interaction.
Conclusions:
- Protein quality control mechanisms, particularly JDPs, are crucial for mitigating amyloid toxicity.
- Understanding JDPs and Hsp70 interactions offers potential therapeutic targets for amyloid-related diseases.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Yeast Signaling

